Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease

Activation and migration of regulatory T cells (Treg) into tissue is critical in control of inflammation, but has not been examined extensively in chronic graft versus host disease (cGVHD). In parallel studies of tissues and blood, we determined that FoxP3(+) T cells increased in proportion to T eff...

Full description

Saved in:
Bibliographic Details
Published inLeukemia Vol. 28; no. 10; pp. 2016 - 2027
Main Authors Imanguli, M M, Cowen, E W, Rose, J, Dhamala, S, Swaim, W, Lafond, S, Yagi, B, Gress, R E, Pavletic, S Z, Hakim, F T
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Activation and migration of regulatory T cells (Treg) into tissue is critical in control of inflammation, but has not been examined extensively in chronic graft versus host disease (cGVHD). In parallel studies of tissues and blood, we determined that FoxP3(+) T cells increased in proportion to T effectors (Teff) in tissue infiltrates in oral and cutaneous lichenoid cGVHD. These FoxP3(+) cells expressed distinguishing phenotypic and functional markers of Treg (CD3(+), CD4(+), CD27(+), ICOS(+) and CD39(+)), not found on FoxP3(-) Teff. Both Teff and FoxP3(+) Treg expressed T-bet and the chemokine receptor CXCR3, however, consistent with a common mechanism of chemokine-mediated migration into tissue. Furthermore, functional markers (ICOS and CD39) and chemokine receptors (CXCR3) were both present in a higher proportion of FoxP3(+) cells in tissues than in peripheral blood, consistent with recruitment and activation of Treg in cGVHD target tissues. Finally, the 'activated' CD45RA(-)FoxP3(hi) subset of Treg cells, which highly express functional markers, were found in comparable frequencies in cGVHD patients and normal controls, despite a significant deficit in naive 'resting' Treg. These findings are consistent with Treg capacity to upregulate functional markers and traffick into tissue in cGVHD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
AUTHOR CONTRIBUTIONS
MMI, JR, SD, WS, SL, BY and FTH performed the experiments and analyzed the results. MMI, EWC and SZP developed cGVHD clinical assessment scales and evaluated cGVHD patients. MMI and EWC performed biopsies used in the immunohistochemistry studies. EWC, REG and SZP provided critical advice on study design and data interpretation. MMI and FTH designed and supervised the research, performed statistical analyses, prepared figures and tables and wrote the manuscript. SZP established and oversees the continuing cGVHD natural history study. All authors reviewed and commented on the manuscript.
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2014.92